Published in Ann Rheum Dis on March 01, 1974
Role of ineffective erythropoiesis in the anaemia of rheumatoid arthritis. Ann Rheum Dis (1977) 1.03
The anaemia of chronic disorders. Postgrad Med J (1983) 0.89
In-vitro studies of ineffective erythropoiesis in rheumatoid arthritis. Ann Rheum Dis (1982) 0.84
Role of ineffective erythropoiesis in anaemia of RA. Ann Rheum Dis (1977) 0.81
Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferrioxamine. Br Med J (Clin Res Ed) (1984) 0.79
Iron deficiency anaemia in patients with rheumatic disease receiving non-steroidal anti-inflammatory drugs: the role of upper gastrointestinal lesions. Ann Rheum Dis (1990) 0.75
DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis (1959) 26.58
Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med (1969) 5.12
The anemia of chronic disorders. Semin Hematol (1966) 2.61
A correlative study of the erythrokinetics and disturbances in iron metabolism associated with the anemia of rheumatoid arthritis. Blood (1959) 2.13
Radioactive iron metabolism and erythrocyte survival studies of the mechanism of the anemia associated with rheumatoid arthritis. J Clin Invest (1957) 2.02
The role of the reticulo-endothelial cell in iron metabolism. Br J Haematol (1960) 1.90
The anaemia of rheumatoid arthritis: the significance of iron deposits in the synovial membrane. Australas Ann Med (1970) 1.88
The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production. Blood (1957) 1.74
The measurement of reticuloendothelial iron release using iron-dextran. Br J Haematol (1971) 1.53
Nature of anaemia in rheumatoid arthritis. 8. Iron content of synovial tissue in patients with rheumatoid arthritis and in normal individuals. Ann Rheum Dis (1968) 1.51
Concentration of iron in synovial membrane, synovial fluid, and serum in rheumatoid arthritis and other joint diseases. Ann Rheum Dis (1968) 1.37
DEFECTIVE REUTILIZATION OF IRON IN THE ANEMIA OF INFLAMMATION. J Lab Clin Med (1965) 1.32
Hematologic abnormalities in rheumatoid arthritis. Semin Arthritis Rheum (1972) 1.28
Characteristics of iron dextran utilization in man. Blood (1969) 1.24
Denaturation of ferritin and its relationship with hemosiderin. J Ultrastruct Res (1963) 1.08
The metabolism of iron-dextran given as a total-dose infusion to iron deficient Jamaican subjects. Br J Haematol (1968) 1.01
Studies of a popliteal synovial fistula. Ann Rheum Dis (1972) 1.01
Synovial iron deposition in rheumatoid arthritis. Arthritis Rheum (1973) 0.95
Lactoferrin--an iron binding protein in synovial fluid. Arthritis Rheum (1973) 0.94
Effect of iron dextran, gold thiosulphate, and hydrocortisone acetate on experimental synovitis in the guinea pig. Ann Rheum Dis (1971) 0.90
Relation of oxidative metabolism to the incorporation of plasma iron into ferritin in vivo. J Biol Chem (1961) 0.89
Studies with doubly labeled iron. I. Simultaneous liquid scintillation counting of isotopes Fe55 and Fe59 as ferrous perchlorate. J Lab Clin Med (1961) 0.89
Some observations on the distribution kinetics of radioactive colloidal iron (Imferon and ferric hydroxide). Acta Med Scand (1957) 0.80
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
The fibromyalgia impact questionnaire: development and validation. J Rheumatol (1991) 5.94
Cardiac surgery report cards: comprehensive review and statistical critique. Ann Thorac Surg (2001) 4.26
Oculocutaneous reaction to oxprenolol. Br Med J (1975) 3.98
Neutrophils in development of multiple organ failure in sepsis. Lancet (2006) 3.64
Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med (1995) 3.60
Disabling fibromyalgia: appearance versus reality. J Rheumatol (1993) 3.34
Implanted tissue cages--a study in rabbits. Br J Plast Surg (1972) 3.18
Familial chronic muco-cutaneous candidiasis. J Med Genet (1972) 2.88
Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol (1973) 2.81
Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57
The use of SI units in reporting results obtained in hospital laboratories. J Clin Pathol (1974) 2.55
Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis (1975) 2.27
A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum (1997) 2.23
Complement metabolism in rheumatoid arthritis. I. Longitudinal studies. Ann Rheum Dis (1973) 2.04
Smoking habits in psoriasis: a case control study. Br J Dermatol (1992) 2.03
Acute abdomen during adjuvant chemotherapy: superior mesenteric artery thrombosis associated with CMF chemotherapy. Clin Oncol (R Coll Radiol) (2001) 2.01
DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA. J Clin Invest (1985) 1.96
A stable standard suspension for red-cell counts. Lab Pract (1966) 1.96
A simple and reliable method for estimating haemoglobin. Bull World Health Organ (1995) 1.94
The effects of different levels of dietary restriction on aging and survival in the Sprague-Dawley rat: implications for chronic studies. Aging (Milano) (2001) 1.93
Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum (1997) 1.85
Quality control in haematology: report of interlaboratory trials in Britain. Br Med J (1969) 1.80
Demand or ideation? Evidence from the Iranian marital fertility decline. Demography (1995) 1.80
Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro. J Clin Invest (1981) 1.79
Neuropsychiatric problems in systemic lupus erythematosus. Br Med J (1972) 1.74
The use of 51Cr-labelled heat-damaged red cells to study splenic function. I. Evaluation of method. Br J Haematol (1966) 1.73
Progress in laboratory control of oral anticoagulants. Lancet (1982) 1.72
Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol (1995) 1.70
Native type II collagen-induced arthritis in the rat. I. Incidence and humoral response to collagen. Ann Rheum Dis (1980) 1.69
Monitoring the acute phase response. BMJ (1988) 1.69
Duplex ultrasound and contrast-enhanced ultrasound versus computed tomography for the detection of endoleak after EVAR: systematic review and bivariate meta-analysis. Eur J Vasc Endovasc Surg (2010) 1.67
The influence of ageing on the in vivo elasticity of human skin. Gerontologia (1969) 1.65
Percutaneous access for endovascular aneurysm repair: a systematic review. Eur J Vasc Endovasc Surg (2010) 1.65
P nucleotides in V(D)J recombination: a fine-structure analysis. Mol Cell Biol (1993) 1.64
Lower extremity amputations--a review of global variability in incidence. Diabet Med (2011) 1.63
ICSH review of the measurement of the erythocyte sedimentation rate. Int J Lab Hematol (2011) 1.60
Attitudes toward genetic research review: results from a survey of human genetics researchers. Public Health Genomics (2011) 1.58
ESR or CRP? A comparison of their clinical utility. Hematology (2007) 1.58
Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: a type of congenital dyserythropoietic anaemia. Br J Haematol (1969) 1.58
Native type II collagen--induced arthritis in the rat: the effect of complement depletion by cobra venom factor. Arthritis Rheum (1981) 1.57
Acromegalic arthropathy. Ann Rheum Dis (1971) 1.56
Nitric oxide and the control of firefly flashing. Science (2001) 1.56
A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. Arthritis Rheum (2008) 1.55
The haematological complications of polycythaemia vera and treatment with radioactive phosphorus. Br J Radiol (1966) 1.54
Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. Arthritis Rheum (1983) 1.54
'Non-tropical idiopathic splenomegaly' ('primary hypersplenism'): a review of ten cases and their relationship to malignant lymphomas. Br J Haematol (1969) 1.53
Minimizing the risk of post-operative pyoderma gangrenosum. Br J Dermatol (1992) 1.53
Field evaluation of a novel haemoglobin measuring device designed for use in a rural setting. S Afr Med J (1997) 1.53
The first case of exophytic pilomatricoma in an Asian male. Pediatr Dermatol (2002) 1.52
The morphological applicability of a novel endovascular aneurysm sealing (EVAS) system (Nellix) in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2013) 1.51
Raynaud's phenomenon as a presenting sign of ovarian adenocarcinoma. J Rheumatol (1995) 1.50
Paroxysmal nocturnal haemoglobinuria. Clin Haematol (1975) 1.49
Fibromyalgia and quality of life: a comparative analysis. J Rheumatol (1993) 1.49
Acquired resistance to treatment with arvin. Lancet (1969) 1.48
Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc Natl Acad Sci U S A (1999) 1.45
Status of present and candidate international reference preparations (IRP) of thromboplastin for the prothrombin time. A report of the Subcommittee for Control of Anticoagulation. Thromb Haemost (1993) 1.45
Prophylactic synovectomy of the joints of the rheumatoid hand. Clinical trial with 4 to 8-year follow-up. Ann Rheum Dis (1971) 1.45
Personalised predictions of endovascular aneurysm repair success rates: validating the ERA model with UK Vascular Institute data. Eur J Vasc Endovasc Surg (2010) 1.45
Hairpin coding end opening is mediated by RAG1 and RAG2 proteins. Mol Cell (1998) 1.44
Stenting for in-stent restenosis: A long-term clinical follow-up. Catheter Cardiovasc Interv (1999) 1.43
Allogeneic bone marrow transplantation for primary myelofibrosis. Br J Haematol (1989) 1.43
Recommendations for reference method for haemoglobinometry in human blood (ICSH standard 1995) and specifications for international haemiglobinocyanide standard (4th edition). J Clin Pathol (1996) 1.43
Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) (1980) 1.41
Lichenoid eruption due to methyldopa. Br Med J (1974) 1.41
An association of polymyalgia rheumatica with myelodysplastic syndromes. J Rheumatol (1994) 1.41
Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol (1997) 1.40
Rheumatoid arthritis and motor neurone disease--an association? Br J Rheumatol (1989) 1.40
The aplastic anaemia--paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol (1967) 1.40
Curettage of small basal cell papillomas with the disposable ring curette is superior to conventional treatment. Br J Dermatol (1994) 1.39
Should the role of EVAR be re-evaluated in light of the 10 year results of EVAR-1? J Cardiovasc Surg (Torino) (2011) 1.38
Evaluation of the haemoglobin colour scale. Bull World Health Organ (2002) 1.38
Treatment of chronic mucocutaneous candidiasis with leucocytes from HL-A compatible sibling. Lancet (1972) 1.37
Extensive bilateral leg ulceration. Clin Exp Dermatol (2012) 1.37
Survival in scleroderma. Ann Rheum Dis (1971) 1.37
Electron-microscope studies of the red cell in paroxysmal nocturnal haemoglobinuria. Br J Haematol (1965) 1.36
Characterization of DNA used to assay sera for anti-DNA antibodies; determination of the specificities of anti-DNA antibodies in SLE and non-SLE rheumatic disease states. J Immunol (1977) 1.36
The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J Rheumatol (1992) 1.34
Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor. Clin Exp Immunol (1972) 1.31
Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann Rheum Dis (1980) 1.30
Developmental trajectories of disruptive behavior problems in preschool children of adolescent mothers. Child Dev (1999) 1.28
Diagnostic value of synovial fluid microscopy: a reassessment and rationalisation. Ann Rheum Dis (1991) 1.28
Splenic atrophy in adult coeliac disease: is it reversible? Gut (1981) 1.28
Mixed connective tisssue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum (1980) 1.26
Solid-phase radioimmunoassay for the detection of antibodies to collagen. J Immunol Methods (1979) 1.26
Eosinophilic fasciitis. Case report and review of the literature. Ann Rheum Dis (1977) 1.23
Localisation of collagen types and fibronectin in cartilage by immunofluorescence. Ann Rheum Dis (1983) 1.23
A rapid thin-layer chromatographic system for Romanowsky blood stains. Stain Technol (1974) 1.23
Hempas: congenital dyserythropoietic anaemia (type II). Q J Med (1973) 1.23
Clinical and ultrastructural aspects of congenital dyserythropoietic anaemia type I. Br J Haematol (1972) 1.22
Ventricular dilation after neonatal periventricular-intraventricular hemorrhage. Natural history and therapeutic implications. Am J Dis Child (1982) 1.21
Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol (1972) 1.20
The activation and reactivation of peripheral lymphocytes in culture. J Cell Sci (1967) 1.20
Work and disability status of persons with fibromyalgia. J Rheumatol (1997) 1.20
Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann Rheum Dis (1987) 1.19
Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arthritis Rheum (1994) 1.19
Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology (1992) 1.18
Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol (1989) 1.17
RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation. Oncogene (2010) 1.17
Carcinoma erysipeloides. Br J Dermatol (1991) 1.17